静脉腔内消融后热诱导血栓形成的分类与治疗单中心经验
该单中心回顾性研究纳入2008至2014年间4799例射频或激光腔内消融手术,识别出70例EHIT患者,其中87%无症状。1-2级EHIT用阿司匹林治疗,3-4级多用系统抗凝,抗凝组无进展,阿司匹林组2例进展,1例出血并发症。
要点
- EHIT发生率约1.5%,多数患者无症状。
- 3-4级EHIT系统抗凝可有效预防血栓进展且出血风险低。
- 1-2级EHIT单用阿司匹林进展风险约3%。
核心结论
- 静脉腔内消融后EHIT发生率约1.5%,与文献报道相似。
- 系统抗凝能有效预防3-4级EHIT进展,出血并发症风险低。
- 1-2级EHIT可单用阿司匹林治疗,进展风险约3%。
研究设计与样本
- 共4799例消融手术,通过国际疾病分类第九版编码识别出70例EHIT患者。
- 收集人口学、合并症、体重指数、CEAP分级、术前抗凝及术前术后超声和手术相关数据,EHIT按超声分为1-4级。
主要发现
- 70例EHIT患者中,87%就诊时无症状,10%报告疼痛,2.9%报告肿胀。
- 系统抗凝治疗的3-4级EHIT患者均未见血栓进展。
- 阿司匹林治疗的1-2级EHIT患者中2例出现血栓进展。
- 1例患者发生出血并发症。
关键数值与推荐
- EHIT按超声检查结果分为1至4级。
- 1-2级EHIT患者接受每日阿司匹林治疗。
- 3-4级EHIT多数患者接受系统抗凝治疗。
- 术后1至2周复查超声评估进展。
临床怎么用
- 术后1-2周常规超声筛查EHIT,按分级选择治疗。
- 3-4级EHIT采用系统抗凝以预防血栓进展。
- 1-2级EHIT可单用阿司匹林,需短期超声随访监测进展。
局限性
- 回顾性单中心设计,样本量有限(70例EHIT)。
- 未设对照组,治疗策略基于分级而非随机分配。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endothermal heat-induced thrombosis (EHIT) is a known complication of endothermal venous ablation procedures. EHIT can lead to deep vein thrombosis/pulmonary embolism, which cause significant disability and, rarely, death. Other studies have evaluated risk factors for EHIT. There is an accepted grading system for EHIT, but there is no consensus on treatment type, duration, or follow-up. We retrospectively evaluated all cases of EHIT after radiofrequency ablation or endovenous laser ablation at our institution during a 7-year period, focusing on classification, treatment, and outcomes of EHIT. METHODS: The analysis included all patients aged >18 years who underwent radiofrequency ablation or endovenous laser ablation at our institution, Spectrum Health Hospital Vein Solutions (Grand Rapids, Mich), between January 1, 2008, and December 31, 2014. Electronic medical records were queried retrospectively to identify patients with EHIT during the study interval by International Classification of Diseases-Ninth Revision code. Demographic data, including age, gender, comorbidities (eg, history of deep venous thrombosis, hypercoagulable state, family history of blood clots, etc), body mass index, Clinical, Etiology, Anatomy, and Pathophysiology (CEAP) classification, and use of preoperative anticoagulation were collected for each patient in the registry. Each patient had a required postoperative duplex ultrasound (US) examination within 1 to 2 weeks of the procedure. Preoperative and postoperative US imaging data and procedure-specific data were also recorded for each patient. EHIT was graded from 1 to 4 by review of the US studies. Each patient's treatment course was reviewed for type of anticoagulation, duration of treatment, follow-up imaging, and outcome. RESULTS: From 2008 to 2014, 4799 ablations were performed at Spectrum Health Hospital Vein Center, and EHIT was identified in 70 patients. At presentation, 87% of patients were asymptomatic, 10% reported pain, and 2.9% reported swelling. Patients with EHIT grades 1 or 2 were treated with daily aspirin, and most of those with grades 3 or 4 were treated with systemic anticoagulation. Repeat US imaging was performed at 1 to 2 weeks to evaluate progression. Progression was not seen in any patients treated with systemic anticoagulation (grades 3-4). Thrombus progression occurred in two patients with grades 1 or 2 EHIT treated with aspirin. A bleeding complication occurred in one patient. CONCLUSIONS: EHIT after endovenous ablation occurred in ∼1.5% of patients, which is similar to that reported in the literature. Our review shows that systemic anticoagulation is effective in the prevention of progression with a low risk of bleeding complications. Patients with EHIT grades 1 or 2 can be treated with aspirin alone with a low risk of progression (3%).
引用
- Korepta LM, Watson JJ, Mansour MA, et al. Outcomes of a single-center experience with classification and treatment of endothermal heat-induced thrombosis after endovenous ablation. J Vasc Surg Venous Lymphat Disord. 2017. PMID: 28411699. doi:10.1016/j.jvsv.2016.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。